The story of copyright's flagship drug presents a complex case for stakeholders in the drug sector. While initially a phenomenal success, generating billions, the exclusivity lapse and the subsequent flood of off-brand https://online-pharmacy326812.uzblog.net/the-little-copyright-and-pharma-a-hazardous-bet-55427292